Detalles de la búsqueda
1.
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Br J Cancer
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519705
2.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Jpn J Clin Oncol
; 54(4): 452-462, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271158
3.
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.
Cancer Sci
; 113(1): 221-228, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704312
4.
Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer.
Oncologist
; 26(1): 19-e52, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918791
5.
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.
Int J Clin Oncol
; 26(9): 1628-1639, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117553
6.
Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer.
BMC Pulm Med
; 21(1): 155, 2021 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964920
7.
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
Cancer Sci
; 110(1): 52-60, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390416
8.
Discovery of a Highly Potent and Broadly Effective Epidermal Growth Factor Receptor and HER2 Exon 20 Insertion Mutant Inhibitor.
Angew Chem Int Ed Engl
; 57(36): 11629-11633, 2018 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978938
9.
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
Invest New Drugs
; 35(4): 529-536, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28317087
10.
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.
Proc Natl Acad Sci U S A
; 111(45): E4869-77, 2014 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25349422
11.
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Cancer Sci
; 107(11): 1667-1676, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581340
12.
Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
Invest New Drugs
; 34(3): 394-6, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26856856
13.
Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.
Cancer Sci
; 106(6): 734-739, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25786335
14.
Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.
Cancer Rep (Hoboken)
; 7(2): e1960, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196303
15.
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
J Clin Invest
; 134(7)2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557498
16.
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy.
JTO Clin Res Rep
; 4(12): 100590, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029041
17.
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Sci Rep
; 13(1): 19729, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957228
18.
Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101).
Clin Lung Cancer
; 24(7): e247-e253, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316381
19.
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
Oncol Lett
; 26(2): 355, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545623
20.
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE).
J Thorac Oncol
; 18(10): 1334-1350, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37364849